Clinical Trials
4 trialsNCT04430842 2023-01-18
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Quadriga Biosciences, Inc.
Phase 1 Completed
NCT03650452 2021-02-18
ELEKTRA
Takeda
Phase 2 Completed
NCT04450160 2020-06-29
AEO
MetVital, Inc.
Phase 2 Unknown
NCT00790400 2017-02-17
EXIST-2
Novartis
Phase 3 Completed